Sneha A Kulkarni1, Si-Shen Feng. 1. Department of Chemical & Biomolecular Engineering, National University of Singapore, Block E5, 02-11 4 Engineering Drive 4, Singapore, 117576, Singapore.
Abstract
PURPOSE: To investigate the effects of the particle size and surface coating on the cellular uptake of the polymeric nanoparticles for drug delivery across the physiological drug barrier with emphasis on the gastrointestinal (GI) barrier for oral chemotherapy and the blood-brain barrier (BBB) for imaging and therapy of brain cancer. METHODS: Various sizes of commercial fluorescent polystyrene nanoparticles (PS NPs) (viz 20 50, 100, 200 and 500 nm) were modified with the d-α-tocopheryl polyethylene glycol 1,000 succinate (vitamin E TPGS or TPGS). The size, surface charge and surface morphology of PS NPs before and after TPGS modification were characterized. The Caco-2 and MDCK cells were employed as an in vitro model of the GI barrier for oral and the BBB for drug delivery into the central nerve system respectively. The distribution of fluorescent NPs after i.v. administration to rats was analyzed by the high performance liquid chromatography (HPLC). RESULTS: The in vitro investigation showed enhanced cellular uptake efficiency for PS NPs in both of Caco-2 and MDCK cells after TPGS surface coating. In vivo investigation showed that the particle size and surface coating are the two parameters which can dramatically influence the NPs biodistribution after intravenous administration. The TPGS coated NPs of smaller size (< 200 nm) can escape from recognition by the reticuloendothelial system (RES) and thus prolong the half-life of the NPs in the blood system. CONCLUSIONS: TPGS-coated PS NPs of 100 and 200 nm sizes have potential to deliver the drug across the GI barrier and the BBB.
PURPOSE: To investigate the effects of the particle size and surface coating on the cellular uptake of the polymeric nanoparticles for drug delivery across the physiological drug barrier with emphasis on the gastrointestinal (GI) barrier for oral chemotherapy and the blood-brain barrier (BBB) for imaging and therapy of brain cancer. METHODS: Various sizes of commercial fluorescent polystyrene nanoparticles (PS NPs) (viz 20 50, 100, 200 and 500 nm) were modified with the d-α-tocopheryl polyethylene glycol 1,000 succinate (vitamin E TPGS or TPGS). The size, surface charge and surface morphology of PS NPs before and after TPGS modification were characterized. The Caco-2 and MDCK cells were employed as an in vitro model of the GI barrier for oral and the BBB for drug delivery into the central nerve system respectively. The distribution of fluorescent NPs after i.v. administration to rats was analyzed by the high performance liquid chromatography (HPLC). RESULTS: The in vitro investigation showed enhanced cellular uptake efficiency for PS NPs in both of Caco-2 and MDCK cells after TPGS surface coating. In vivo investigation showed that the particle size and surface coating are the two parameters which can dramatically influence the NPs biodistribution after intravenous administration. The TPGS coated NPs of smaller size (< 200 nm) can escape from recognition by the reticuloendothelial system (RES) and thus prolong the half-life of the NPs in the blood system. CONCLUSIONS: TPGS-coated PS NPs of 100 and 200 nm sizes have potential to deliver the drug across the GI barrier and the BBB.
Authors: C Navarro; I González-Álvarez; M González-Álvarez; M Manku; V Merino; V G Casabó; M Bermejo Journal: Eur J Pharm Sci Date: 2010-12-21 Impact factor: 4.384
Authors: Roberta Cavalli; Alessandro Bargoni; Valerio Podio; Elisabetta Muntoni; Gian Paolo Zara; Maria Rosa Gasco Journal: J Pharm Sci Date: 2003-05 Impact factor: 3.534
Authors: Parag Aggarwal; Jennifer B Hall; Christopher B McLeland; Marina A Dobrovolskaia; Scott E McNeil Journal: Adv Drug Deliv Rev Date: 2009-04-17 Impact factor: 15.470
Authors: Hongyu Chen; Bin Qi; Thomas Moore; Fenglin Wang; Daniel C Colvin; Liurukara D Sanjeewa; John C Gore; Shiou-Jyh Hwu; O Thompson Mefford; Frank Alexis; Jeffrey N Anker Journal: Small Date: 2014-04-19 Impact factor: 13.281
Authors: Albert Harguindey; Shambojit Roy; Alexander W Harris; Benjamin D Fairbanks; Andrew P Goodwin; Christopher N Bowman; Jennifer N Cha Journal: Biomacromolecules Date: 2019-03-26 Impact factor: 6.988
Authors: Xiaopin Duan; Christina Chan; Nining Guo; Wenbo Han; Ralph R Weichselbaum; Wenbin Lin Journal: J Am Chem Soc Date: 2016-12-15 Impact factor: 15.419
Authors: Vanessa Sainz; Liane I F Moura; Carina Peres; Ana I Matos; Ana S Viana; Angela M Wagner; Julia E Vela Ramirez; Teresa S Barata; Manuela Gaspar; Steve Brocchini; Mire Zloh; Nicholas A Peppas; Ronit Satchi-Fainaro; Helena F Florindo Journal: Acta Biomater Date: 2018-06-22 Impact factor: 8.947
Authors: Rokon Uz Zaman; Nihal S Mulla; Keegan Braz Gomes; Cherilyn D'Souza; Kevin Sean Murnane; Martin J D'Souza Journal: Int J Pharm Date: 2018-07-19 Impact factor: 5.875
Authors: Haijiang Lin; Yueran Yue; Daniel E Maidana; Peggy Bouzika; Alp Atik; Hidetaka Matsumoto; Joan W Miller; Demetrios G Vavvas Journal: Semin Ophthalmol Date: 2016 Impact factor: 1.975